Theme

Tumor-type
specific Sessions

Session Title

DIPG (clinical)

Presentation
No.

Abstract
No.

Lecture title

SpeakerCountry

DIPC-O-01

DIPG-35

Biological medicine for Diffuse Intrinsic Pontine Glioma (DIPG) eradication: Results ofthe three arm biomarker-driven randomized BIOMEDE 1.0 trial

Jacques Grill

FranceDIPC-O-02

DIPG-52

Phase I clinical trial of ONC201 in pediatric H3 K27M-mutant glioma or newly
diagnosed DIPG

Sharon Gardner

USA

DIPC-O-03

DIPG-84

Complementary and alternative medicine in diffuse intrinsic pontine glioma

Fatma El-Khouly

Netherlands

DIPC-P-04

DIPG-28

Repeated low dose RT for pediatric DIPG – Less disease burden with comparable
outcomes

Yao Yu WuTaiwan

DIPC-P-05

DIPG-42

Toward multimodality therapy for DIPG/DMG: Development and investigation ofcraniospinal irradiation and convection-enhanced delivery PDX models

Adam GreenUSA

DIPC-P-06

DIPG-46

Non-DIPG patients enrolled in the International DIPG Registry: Histopathologic
evaluation of central neuro-imaging review

Margot Lazow

USA

DIPC-P-07

DIPG-75

Precision medicine for paediatric high-grade diffuse midline gliomas - Results from theZero Childhood Cancer comprehensive precision medicine program

Dong-Anh Khuong-Quang

Australia

DIPC-P-08

DIPG-74

Re-irradiation of DIPG: Data from the International DIPG Registry

Doug StrotherCanada

DIPC-P-09

DIPG-77

Treatment extent and the effect on survival in diffuse intrinsic pontine glioma

Joshua Baugh

Netherlands

DIPC-P-10

DIPG-17

Biopsy-proven diffuse midline glioma in adolescents and young adults

Shota Tanaka

Japan

DIPC-P-11

DIPG-33

Characterizing the neuro-vascular unit in diffuse intrinsic pontine glioma

Fatma El-KhoulyNetherlands

DIPC-P-12

DIPG-37

Predicting outcome in childhood diffuse midline gliomas using magnetic resonanceimaging based texture analysis

Elwira Szychot

UKDIPC-P-13

DIPG-66

Feasibility and applicability of molecular guided therapy in high grade glioma/diffuse
midline glioma: Results from Beat Childhood Cancer NMTRC-009 Molecular Guided
Therapy study

Virginia Harrod

USADIPC-P-14

DIPG-61

Rescue regimens after BIOMEDE: possible influence on OS assessment

Jacques Grill

FranceDIPC-P-15

DIPG-20

Determination and management of hydrocephalus in patients with DIPG, an institutional
Adriana Fonseca
experience

CanadaDIPC-P-16

DIPG-49

Brainstem and pontine volumetric analysis as a surrogate measure of local disease
control in children with diffuse intrinsic pontine glioma (DIPG)

Mark Souweidane

USADIPC-P-17

DIPG-55

Patterns of cerebrospinal fluid diversion and survival in children with diffuse intrinsic
pontine glioma: a report from the International DIPG Registry

Tabitha CooneyUSA

DIPC-P-18

DIPG-01

Reirradiation practices for diffuse intrinsic pontine glioma

Chantel Cacciotti

USA

DIPC-P-19

DIPG-25

Ketogenic diet in diffuse intrinsic pontine glioma in children: a retrospective study
investigating the feasibilityAlexandre Perez

Switzerland

DIPC-P-20

DIPG-38

Addition of multimodal immunotherapy to combination treatment strategies for children
with DIPG: final results of a cohort of children

Stefaan Van Gool

Germany

DIPC-P-21

DIPG-72

Long-term survival of a classic diffuse intrinsic pontine glioma treated withnimotuzumab

Sidnei Epelman

BrazilDIPC-P-22

DIPG-11

A Phase I dose escalation study of BXQ-350 in children and young adults with relapsed
Mohamed AdelBaki,solid tumors

USADIPC-P-23

DIPG-26

Therapeutic effects of radiotherapy with concomitant and adjuvant temozolomide
versus radiotherapy with concomitant temozolomide alone in children with DIPG : asingle-center experience with 82 cases

Mingyao Lai

China

DIPC-P-24

DIPG-02

Usefulness of bevacizumab in maintaining quality of life at the time of diffuse intrinsic
pontine glioma relapse

Akira Gomi

JapanDIPC-P-25

DIPG-80

Clinical and radiographic response to ONC201 in a pediatric patient with a thalamic
H3K27M and BRAFV600E mutant diffuse midline high grade glioma

Lindsay KilburnUSA

DIPC-P-26

DIPG-23

Single case report of low dose radiotherapy and chemotherapy in the treatment of DIPG Chen Kan Tseng

DIPC-P-27

DIPG-04

Therapeutic strategy for diffuse midline gliomas. A single center experience

Takumi Yamanaka

TaiwanJapan